| Document |
Document Title |
|
WO/2017/170826A1 |
The purpose of the invention is to provide a compound useful in the prevention or treatment of diabetes, obesity, and conditions related thereto. The present invention relates to an enhancing agent for glucagon-like peptide-1 receptor ac...
|
|
WO/2017/173105A1 |
Reagents for stabilizing the nucleic acids of a biological cell, compositions, kits and methods of use thereof are described. The stabilization reagents may prepare the nucleic acids within the biological cell for storage and preserve th...
|
|
WO/2017/171376A1 |
The present specification relates to a compound of the chemical formula 1 and an organic electronic element comprising the compound.
|
|
WO/2017/170093A1 |
The present invention relates to a furfural composition which contains furfural as a main component, and which is configured such that: the content of furfural in the furfural composition is 98% by mass or more relative to the total mass...
|
|
WO/2017/162204A1 |
The present invention discloses a manufacturing method of a benzofuran analog and an intermediate and crystalline form of same.
|
|
WO/2017/162668A1 |
The invention provides a stable epoprostenol sodium and a process for the preparation this pharmaceutically active ingredient.
|
|
WO/2017/163894A1 |
Provided are: a tetracarboxylic dianhydride represented by formula (1) and a method for producing the tetracarboxylic dianhydride; and a polyamic acid and a polyimide each produced from the tetracarboxylic dianhydride.
|
|
WO/2017/164379A1 |
Provided is a method for producing a 2-alkylcarbonylnaphtho[2,3-b]furan-4,9-dione-related substance, which is suitable for the production on an industrial scale. The present invention provides: a method for producing an intermediate for ...
|
|
WO/2017/161452A1 |
This invention relates to a method for the conversion of lignocellulosic biomass into ethyl esters of carboxylic acids. Said method consists of treating the biomass material with an oxidizing agent that is incorporated in an solution com...
|
|
WO/2017/165233A1 |
The disclosure provides compounds of formula (I), including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected...
|
|
WO/2017/156688A1 |
Disclosed in the present invention is a preparation method for a nitroolefin derivative, the method comprising the following steps: adding an ethylene compound, sodium nitrite, manganese dioxide and 2,2,6,6-tetramethylpiperidinyloxy to a...
|
|
WO/2017/158106A1 |
The present invention relates to a method for preparing furoic acid or a derivative thereof of formula (I), wherein R1, R2, R3 and R4 represent, independently of one another, a hydrogen atom, a linear or branched C1-C6 alkyl group, a -C(...
|
|
WO/2017/160925A1 |
Disclosed herein are compounds of Formulae (I), and (II), methods of synthesizing compounds of Formulae (I) and (II), and methods of using compounds of Formulae (I) and (II) as an analgesic.
|
|
WO/2017/160552A1 |
Disclosed herein novel dopamine D3 receptor selective antagonists/partial agonists compounds with high affinity and metabolic stability useful for the treatment of psychiatric and neurological disorders and as research and diagnostic too...
|
|
WO/2017/157936A1 |
This invention relates to a combined process for the production of tetrahydrofuran and polyesters and copolyesters comprising repetitive 1,4-butylene dicarboxylate units.
|
|
WO/2017/153952A1 |
The invention is directed to substituted salicylamide derivatives. Specifically, the invention is directed to compounds according to Formula (I): wherein R, R1 and R2 are as defined herein, or a pharmaceutically acceptable salt thereof. ...
|
|
WO/2017/153731A1 |
A compound of formula (I) wherein Z is a group of formula (II) and Core is selected from groups of formula (IIIa) or (IIIb) wherein X is S or O; R1 is a substituent; n is 0 or a positive integer; Ar1 independently in each occurrence is a...
|
|
WO/2017/155286A2 |
The present invention provides a catalyst for carboxylation of furan-based compounds or derivatives thereof comprising a hydroxyl group and a carbonyl group, which is a catalyst for preparing 2,5-furancarboxylic acid (FDCA) including nob...
|
|
WO/2017/151625A1 |
The present disclosure provides compounds of Formulas (I), (II), and pharmaceutically acceptable salts thereof. The compounds described herein are useful in treating proliferative diseases, for example, cancer (e.g., lung cancer), and in...
|
|
WO/2017/147893A1 |
The present invention relates to a compound represented by formula (III), R being selected from C1-C4 alkyls, substituted or unsubstituted phenyl or substituted or unsubstituted benzyl, and being preferably selected from isopropyl; and t...
|
|
WO/2017/146405A1 |
Disclosed are an organic electronic element and an electronic device including the same, the organic electronic element comprising: a compound represented by chemical formula 1; a first electrode; a second electrode; and an organic layer...
|
|
WO/2017/144863A1 |
A compound of formula (I) or (III) (Formulae (I), (III)) wherein: one Y is a substituent R1 bound directly to the fluorene unit of formula (I) by an sp3-hybridised carbon atom; the other Y is an aryl or heteroaryl group Ar1 that may be u...
|
|
WO/2017/144150A2 |
The present invention relates to a process to produce compounds of the formula (1) which are suitable for use in electronic devices, as well as to intermediate compounds of formula (lnt-1) and compounds of formula (1-1) and (1-2) obtaine...
|
|
WO/2017/146474A1 |
The present specification relates to a heterocyclic compound and an organic light emitting diode containing same.
|
|
WO/2017/146581A1 |
Described are methods for preparing phenols, benzene carboxylic acids, esters and anhydrides thereof from furanic compounds by reaction with a dienophile, wherein the furanic compounds are reacted with a hydrazine and/or oxime and then r...
|
|
WO/2017/146522A1 |
The present specification relates to a heterocyclic compound and an organic light emitting diode containing same.
|
|
WO/2017/146466A1 |
The present specification relates to a heterocyclic compound and an organic light emitting element comprising the same.
|
|
WO/2017/146483A1 |
The present specification relates to a heterocyclic compound and an organic light emitting diode containing same.
|
|
WO/2017/143446A1 |
The disclosure provides compositions comprising tricarboxylic acid cycle intermediates and at least one anti-oxidant. In one embodiment, the composition comprises pyruvic acid, citric acid and malic acid in combination with the anti-oxid...
|
|
WO/2017/143892A1 |
A sulfonic acid ester acaricide containing spiro rings, the structure thereof being shown in formula I; the present compound has an inhibiting and killing effect on pest mites and mite eggs, and can be used as an acaricide for preventing...
|
|
WO/2017/142000A1 |
In the present invention, a sugar alcohol can be efficiently produced from a cellulose-containing biomass by carrying out a step (1) of filtering an aqueous sugar solution, which is obtained by hydrolysis of a cellulose-containing biomas...
|
|
WO/2017/142308A1 |
The present specification provides a heterocyclic compound and an organic electroluminescent device comprising same.
|
|
WO/2017/142304A1 |
The present specification provides a heterocyclic compound and an organic electroluminescent device comprising same.
|
|
WO/2017/142310A1 |
The present specification provides a heterocyclic compound and an organic electroluminescent device comprising same.
|
|
WO/2017/139664A1 |
The invention relates to methods and intermediates useful in the synthesis of eribulin.
|
|
WO/2017/138755A1 |
The present specification provides a heterocyclic compound and an organic electroluminescent device containing the same.
|
|
WO/2017/135717A1 |
Disclosed are an organic electric element and an electronic device comprising the same, the organic electric element comprising a compound represented by chemical formula 1, a first electrode, a second electrode, and an organic material ...
|
|
WO/2017/133464A1 |
Disclosed are amidated arylbenzofuran derivatives, pharmaceutical use thereof and a preparation method therefor. The derivatives have antioxidant activity and xanthine oxidase inhibitory activity, and can be used for preparing compositio...
|
|
WO/2017/134505A1 |
The present invention relates to a system for producing energy from sewage and agricultural and domestic waste by means of four apparatuses. The waste or product from each apparatus is used as feedstock or a catalyst in a process carried...
|
|
WO/2017/129796A1 |
The present invention relates to a method of carrying out an organic reaction in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose.
|
|
WO/2017/130079A1 |
A novel light-emitting element is provided. A light-emitting element with a long lifetime is provided. A light-emitting element with high emission efficiency is provided. A novel organic compound is provided. A novel organic compound hav...
|
|
WO/2017/130679A1 |
Provided is a method with which it is possible to produce a high-purity thiocarbonyl compound via an industrially practicable production method by removing a sulfurizing agent-derived byproduct via a simple post-reaction purification met...
|
|
WO/2017/126847A1 |
The present invention relates to a method for preparing a 3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofurane-2-yl)
propanol derivative simply and in high yield, and an intermediate therefor.
|
|
WO/2017/127753A1 |
This invention is directed to methods of preparing AQX-1125 having the formula (I). This invention is also directed to intermediates utilized in the methods of preparing AQX-1125.
|
|
WO/2017/126818A1 |
Disclosed are a compound represented by chemical formula 1, an organic electronic element comprising a first electrode, a second electrode, and an organic layer between the first electrode and the second layer, and an electronic device c...
|
|
WO/2017/123008A1 |
An organic light-emitting device and an organic light-emitting display device comprising same are disclosed. The organic light-emitting device and the organic light-emitting display device comprising same, according to the present invent...
|
|
WO/2017/121855A1 |
The present invention relates to compounds of formula (I) These compounds are useful in the treatment of many diseases such as a skin disease, an allergy, an autoimmune disease, a cardiovascular disease, a lung disease, asthma, a bacteri...
|
|
WO/2017/122754A1 |
A compound represented by general formula (I), a tautomer or stereoisomer of said compound, or a pharmaceutically acceptable salt thereof, or a solvate of these is used as a voltage-dependent T-type calcium channel inhibitor. (In the for...
|
|
WO/2017/123763A1 |
The present disclosure provides processes for the production of 2-5-furandicarboxylic acid (FDCA) and intermediates thereof by the chemocatalytic conversion of a furanic oxidation substrate. The present disclosure further provides proces...
|
|
WO/2017/119654A1 |
Disclosed are an organic electronic element and an electronic apparatus comprising the same, the organic electronic element comprising a compound represented by chemical formula 1, a first electrode, a second electrode, and an organic ma...
|
